Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis
Pihong Li,1,* Qiaolin Wu,2,* Yihan Sun,1,* Xiaoyu Pan,1 Yifan Han,1 Bing Ye,1 Yinlong Zhang,1 Jianda Dong,1 Zhouci Zheng1 1Departments of Neck Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China; 2Departments of Anesthesiolog...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-12-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/downregulation-of-cdh16-in-papillary-thyroid-cancer-and-its-potential--peer-reviewed-article-CMAR |
_version_ | 1811330475087626240 |
---|---|
author | Li P Wu Q Sun Y Pan X Han Y Ye B Zhang Y Dong J Zheng Z |
author_facet | Li P Wu Q Sun Y Pan X Han Y Ye B Zhang Y Dong J Zheng Z |
author_sort | Li P |
collection | DOAJ |
description | Pihong Li,1,* Qiaolin Wu,2,* Yihan Sun,1,* Xiaoyu Pan,1 Yifan Han,1 Bing Ye,1 Yinlong Zhang,1 Jianda Dong,1 Zhouci Zheng1 1Departments of Neck Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China; 2Departments of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jianda Dong; Zhouci ZhengDepartments of Neck Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of ChinaEmail necksurgery@126.com; 424505514@qq.comObjective: Thyroid cancer has the highest prevalence among the cancer types that affect the endocrine system; however, its molecular mechanisms are not yet determined. Cadherin-16 (CDH16) plays an important role in the tumorigenesis of human cancers, but its influence on papillary thyroid cancer (PTC) is poorly investigated. This study aimed to explore the role of CDH16 in PTC.Methods: We performed quantitative real-time polymerase chain reaction to investigate CDH16 expression in PTC. The clinical significance of CDH16 expression in PTC was then evaluated using The Cancer Genome Atlas (TCGA) database. Bioinformatics analysis was also conducted to determine the potential molecular mechanisms of CDH16.Results: CDH16 was remarkably downregulated in PTC tumors compared with that in corresponding normal thyroid tissues in the local and TCGA cohorts. This downregulation was associated with unfavorable clinicopathological features, including histological type, high tumor stage, aggressive lymph node metastasis (LNM), and advanced clinical stage. In addition, logistic analyses revealed that the reduced expression of CDH16 can aggravate the risk of LNM in PTC. Bioinformatics analysis indicated that the co-expressed CDH16 genes mainly participated in signaling the cancer-related pathways.Conclusion: CDH16 is involved in PTC progression and acts as an LNM-related gene in PTC.Keywords: CDH16, papillary thyroid cancer, lymph node metastasis, co-expression, mechanism |
first_indexed | 2024-04-13T16:02:26Z |
format | Article |
id | doaj.art-b4d82d7c8a894fdfa2b83214f2f47004 |
institution | Directory Open Access Journal |
issn | 1179-1322 |
language | English |
last_indexed | 2024-04-13T16:02:26Z |
publishDate | 2019-12-01 |
publisher | Dove Medical Press |
record_format | Article |
series | Cancer Management and Research |
spelling | doaj.art-b4d82d7c8a894fdfa2b83214f2f470042022-12-22T02:40:30ZengDove Medical PressCancer Management and Research1179-13222019-12-01Volume 11107191072950664Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico AnalysisLi PWu QSun YPan XHan YYe BZhang YDong JZheng ZPihong Li,1,* Qiaolin Wu,2,* Yihan Sun,1,* Xiaoyu Pan,1 Yifan Han,1 Bing Ye,1 Yinlong Zhang,1 Jianda Dong,1 Zhouci Zheng1 1Departments of Neck Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China; 2Departments of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jianda Dong; Zhouci ZhengDepartments of Neck Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of ChinaEmail necksurgery@126.com; 424505514@qq.comObjective: Thyroid cancer has the highest prevalence among the cancer types that affect the endocrine system; however, its molecular mechanisms are not yet determined. Cadherin-16 (CDH16) plays an important role in the tumorigenesis of human cancers, but its influence on papillary thyroid cancer (PTC) is poorly investigated. This study aimed to explore the role of CDH16 in PTC.Methods: We performed quantitative real-time polymerase chain reaction to investigate CDH16 expression in PTC. The clinical significance of CDH16 expression in PTC was then evaluated using The Cancer Genome Atlas (TCGA) database. Bioinformatics analysis was also conducted to determine the potential molecular mechanisms of CDH16.Results: CDH16 was remarkably downregulated in PTC tumors compared with that in corresponding normal thyroid tissues in the local and TCGA cohorts. This downregulation was associated with unfavorable clinicopathological features, including histological type, high tumor stage, aggressive lymph node metastasis (LNM), and advanced clinical stage. In addition, logistic analyses revealed that the reduced expression of CDH16 can aggravate the risk of LNM in PTC. Bioinformatics analysis indicated that the co-expressed CDH16 genes mainly participated in signaling the cancer-related pathways.Conclusion: CDH16 is involved in PTC progression and acts as an LNM-related gene in PTC.Keywords: CDH16, papillary thyroid cancer, lymph node metastasis, co-expression, mechanismhttps://www.dovepress.com/downregulation-of-cdh16-in-papillary-thyroid-cancer-and-its-potential--peer-reviewed-article-CMARcdh16papillary thyroid cancerlymph node metastasisco-expressionmechanism |
spellingShingle | Li P Wu Q Sun Y Pan X Han Y Ye B Zhang Y Dong J Zheng Z Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis Cancer Management and Research cdh16 papillary thyroid cancer lymph node metastasis co-expression mechanism |
title | Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis |
title_full | Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis |
title_fullStr | Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis |
title_full_unstemmed | Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis |
title_short | Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis |
title_sort | downregulation of cdh16 in papillary thyroid cancer and its potential molecular mechanism analysed by qrt pcr tcga and in silico analysis |
topic | cdh16 papillary thyroid cancer lymph node metastasis co-expression mechanism |
url | https://www.dovepress.com/downregulation-of-cdh16-in-papillary-thyroid-cancer-and-its-potential--peer-reviewed-article-CMAR |
work_keys_str_mv | AT lip downregulationofcdh16inpapillarythyroidcanceranditspotentialmolecularmechanismanalysedbyqrtpcrtcgaandinsilicoanalysis AT wuq downregulationofcdh16inpapillarythyroidcanceranditspotentialmolecularmechanismanalysedbyqrtpcrtcgaandinsilicoanalysis AT suny downregulationofcdh16inpapillarythyroidcanceranditspotentialmolecularmechanismanalysedbyqrtpcrtcgaandinsilicoanalysis AT panx downregulationofcdh16inpapillarythyroidcanceranditspotentialmolecularmechanismanalysedbyqrtpcrtcgaandinsilicoanalysis AT hany downregulationofcdh16inpapillarythyroidcanceranditspotentialmolecularmechanismanalysedbyqrtpcrtcgaandinsilicoanalysis AT yeb downregulationofcdh16inpapillarythyroidcanceranditspotentialmolecularmechanismanalysedbyqrtpcrtcgaandinsilicoanalysis AT zhangy downregulationofcdh16inpapillarythyroidcanceranditspotentialmolecularmechanismanalysedbyqrtpcrtcgaandinsilicoanalysis AT dongj downregulationofcdh16inpapillarythyroidcanceranditspotentialmolecularmechanismanalysedbyqrtpcrtcgaandinsilicoanalysis AT zhengz downregulationofcdh16inpapillarythyroidcanceranditspotentialmolecularmechanismanalysedbyqrtpcrtcgaandinsilicoanalysis |